All In Biotech

Free tool

FAERS Monitor: Atelvia

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022560 or its brand name (Atelvia, Risedronate Sodium). Reports on generic versions are filed under their own applications.

Reports

13,245

Serious

11,961

90% of reports

Hospitalization

5,596

Death reported

1,836

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pain2,586
  • drug ineffective2,547
  • off label use2,520
  • vomiting2,310
  • drug hypersensitivity2,305
  • dyspnoea2,272
  • arthralgia2,259
  • pneumonia2,083
  • fatigue1,975
  • rheumatoid arthritis1,904
  • wheezing1,886
  • asthma1,857
  • nausea1,823
  • malaise1,802
  • diarrhoea1,791

Reports by year received

View as table
YearReports
2004228
2005261
2006138
2007247
2008316
2009217
2010169
2011220
2012313
2013168
2014136
2015207
2016286
2017196
2018315
2019524
20201,019
20211,143
20221,435
20231,435
20241,666
20251,640
2026966

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,914 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
wheezingSignal1,88652.150.091,781
rheumatoid arthritisSignal1,90427.126.047,230
asthmaSignal1,85726.525.445,057
drug hypersensitivitySignal2,30519.118.439,479
pneumoniaSignal2,08310.39.917,592
arthralgiaSignal2,2598.78.315,543
vomitingSignal2,3107.87.514,014
painSignal2,5866.76.512,881
malaiseSignal1,8026.56.38,609
dyspnoeaSignal2,2726.46.210,579
off label useSignal2,5204.64.47,334
diarrhoeaSignal1,7914.44.24,865
fatigueSignal1,9754.03.94,669
nauseaSignal1,8233.73.53,658
drug ineffectiveSignal2,5473.13.03,790

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.